Endoscopic Observation of Tissue by Narrowband Illumination

We propose a new illumination method for a medical endoscope: narrow band imaging (NBI), in which the spectral bandwidth of the filtered light is narrowed. To confirm how the spectral specifications of the filtered light influence a reproduced image, an experiment was conducted observing the endoscopic images of the back mucosa of a human tongue. In addition, the effect of NBI on endoscopic images was investigated through preliminary clinical tests in colonoscopy and upper gastrointestinal endoscopy. It has been shown that NBI can enhance the capillary pattern and the crypt pattern on the mucosa. These patterns are useful features for diagnosing an early cancer.     

红珍珠降糖胶囊中微量元素营养研究

红珍珠降糖胶囊是具有显著降低血糖水平,确定糖尿病患者康复的绿色营养保健食品。通过红珍珠降糖胶囊中Cr、Mn、Cu、Zn、Mg等微量元素的分析测试以及与青海小麦、膳食日摄取量等对比研究,表明红珍珠降糖胶囊富含涉及糖尿病的微量元素,在降低血粮糖水平方面具有十分重要的营养学、功效学作用和意义。     

LIGHT-SCATTERING STUDY OF POLYELECTROLYTE HOLLOW CAPSULES

Silver halide (AgX) microcrystal was used as template to synthesize hollow polyelectrolyte capsules. These hollow capsules were characterized by laser light scattering (LLS) used to measure the size of the capsules in solution. The ratio of hydrodynamic radius (Rh) from dynamic LLS to the radius of gyration (Rg) from static LLS is almost unity, revealing that the entities are hollow in solution. The results suggest that the LLS method can be regarded as a good complement to the confocal laser scanning microscopy (CLSM) method for the characterization of small hollow capsules, and it possesses the advantage of not needing fluorescence labeling.     

Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

银菊珍珠胶囊中稀土元素的电感耦合等离子体质谱分析

建立了一种电感耦合等离子体质谱法测定银菊珍珠胶囊中稀土元素的方法。利用该方法分析了国家一级灌木枝叶标准物质（GBW 07603）和国际柑橘叶标准物质（NIST1572）中的稀土元素，结果与标准值一致。该方法已被用于分析银菊珍珠肢囊样品中的稀土元素。     

胶束增强型聚电解质微胶囊的制备

采用杂化碳酸钙微球作为模板, 利用LbL技术, 选择聚苯乙烯磺酸钠(PSS), 烯丙基胺的盐酸盐(PAH)和二烯丙基二甲基胺盐酸盐(PADA)聚电解质, 分别组装了PAH/PSS(弱/强)聚电解质胶囊和PADA/PSS(强/强)聚电解质微胶囊. 除去模板后得到了球形良好、分散均匀的聚电解质微胶囊. 研究结果表明, 利用杂化碳酸钙微球作为聚电解质微胶囊的模板, 得到的微胶囊的囊壁厚而致密, 同时, 由于组装采用的聚电解质的种类不同, 囊壁的微观形貌有较大差异.     

盐酸环丙沙星及其制剂含量测定方法的探讨

非水滴定法测定盐酸环丙沙星的含量时，需要预先加入冰乙酸和乙酸汞进行转化处理，两种试剂的加入顺序对盐酸环丙沙星的溶解速度影响较大，先加入乙酸汞时，盐酸环丙沙星溶解较快。用高效液相色谱法测定盐酸环丙沙星片及盐酸环丙沙星胶囊的含量时，如果以水作溶剂，测定值明显偏低，宜改用0.l mol／L盐酸溶液作溶剂。     

Stable Hydrogen-Bonded Spherical Capsules Formed from Self-Assembly of Pyrogallol[4]arenes

The self-assemblies of two pyrogallol[4]arenes held together by 48 intermolecular hydrogen bonds stably associate in the form of spherical hexameric capsules. The molecular structures of two hexameric capsules with large interior space were analyzed by single crystal X-ray crystallography.     

The profiling and identification of chemical components,prototypes and metabolites of Run‐zao‐zhi‐yang capsule in rat plasma,urine and bile by an UPLC‐Q‐TOF/MSE‐based high‐throughput strategy

Run‐zao‐zhi‐yang (RZZY) capsule, a traditional Chinese medicine formula, is popularly used for the treatment of dermatitis and eczema. However, few studies have been carried out on RZZY and its metabolites. In this study, we developed a three‐step strategy to rapidly characterize the chemical constituents and metabolites of RZZY using ultra‐high‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry. A total of 41 chemical components were characterized from RZZY. Among these, there are 11 flavonoids, six alkaloids, six stilbene glycosides, five anthraquinones and 13 other compounds. In addition, 18 prototypes and 35 metabolites were detected in rat plasma, urine and bile. This study offers an applicable approach for high‐throughput profiling and identification of chemical components and metabolites derived from traditional Chinese medicine formula in vivo, and also provides essential data for exploring bioactive ingredients and action mechanisms of RZZY.